Long-term Cognitive Impairment in ICU Patients, Admitted for COVID-19 Pneumonia: a Single Centre, Prospective Cohort Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Covid19
- Sponsor
- Ziekenhuis Oost-Limburg
- Enrollment
- 70
- Locations
- 1
- Primary Endpoint
- Neurocognitive impairment measured by RBANS
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
Acute Respiratory Distress syndrome (ARDS) is a pulmonary systematic inflammatory response, leading to acute respiratory failure with hypoxia and/or hypercarbia. COVID-19 evokes a viral pneumonia, which may result in ARDS as well. It is not yet clear if COVID-19 disease behaves like the typical ARDS. Corona virus causes primarily deep hypoxia. Hypoxia, on its own, can lead to long term cognitive impairment. However, critical illness also affects long-term neurocognitive functioning. The investigators will be researching the possibility of long-term cognitive impairment in COVID-19 ICU patients, in comparison with reference values of a healthy population as well as the values measured in critically ill patients, admitted not only for respiratory reasons.
Detailed Description
The investigators will conduct a single centre, prospective cohort study. COVID-19 patients from the Ziekenhuis Oost-Limburg cohort will be contacted by phone 6 months after admission at the ICU. Patients will be asked to participate in a study surrounding long term symptoms of COVID-19. When consent is given by the patiënt, the experimenter will conduct a short questionnaire over the phone with the patient or relative that is present at the time of the call. If the participant is fluent in Dutch, the experimenter will ask permission to visit their home to conduct more testing.
Investigators
Dieter Mesotten
MD
Ziekenhuis Oost-Limburg
Eligibility Criteria
Inclusion Criteria
- •Admitted to the intensive care unit of Ziekenhuis Oost-Limburg
- •Being hospitalized between March 2020 and May 2020, and therefore being admitted 6 months prior to the study
- •The reason of hospitalization was COVID-19 disease
Exclusion Criteria
- •No willingness to participate, and therefore not having signed the informed consent
Outcomes
Primary Outcomes
Neurocognitive impairment measured by RBANS
Time Frame: 6 months after admission at the intensive care unit
the Repeatable Battery for the Assessment of Neuropsychological Statusis (RBANS) is a neuropsychological test that provides information about 5 domains of cognition (1) immediate and (2) delayed memory, (3) attention, (4) visuospatial construction and (5) language) and provides a total score. It is a test that takes about 30 minutes and consists of twelve tests. These are: (1) List Learning, (2) Story Memory, (3) Figure Copy, (4) Line Orientation, (5) Picture Naming, (6) Semantic Fluency, (7) Digit Span, (8) Coding, (9) List Recall, (10) List Recognition, (11) Story Recall and (12) Figure Recall. According to the RBANS manual, the possible values for the RBANS scores at the item, domain, and scale level are 0 to 89, 40 to 154, and 40 to 160
Secondary Outcomes
- Neurocognitive impairment measured by TMT(6 months after admission at the intensive care unit)
- Neurocognitive impairment by the short IQCODE(6 months after admission at the intensive care unit)